IRIS

Benzene

CASRN 71-43-2 | DTXSID3039242

IRIS Toxicological Review of Benzene (Noncancer Effects)

On this page:

Notice - This site contains archived material(s)

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance. Please use the contact us form if you need additional support.


Overview

Benzene, also known as benzol, is widely used as an industrial solvent, as an intermediate in chemical syntheses, and as a component of gasoline; hence, the potential for human exposure is great. The emphasis of this document is a discussion of the noncancer adverse health effects of benzene including the no-observed-adverse-effect levels, the lowest-observed-adverse-effect levels, benchmark dose analysis, uncertainty factors, and any other considerations used to develop the reference dose (RfD) and reference concentration (RfC) for benzene.

The Toxicological Review concludes that chronic benzene exposure may pose several types of noncancer human health hazards. Hematotoxicity, e.g., progressive deterioration of hematopoietic function, has been consistently reported to be the most sensitive indicator of noncancer toxicity in both experimental animal studies and occupationally exposed humans. The hazards can result from inhalation, oral or dermal exposure, though the exposure circumstances vary. The Toxicological Review includes estimates of chronic exposure levels for oral exposure (RfD) and inhalation exposure (RfC) that are thought to be without appreciable risk.


Citation

U.S. EPA. IRIS Toxicological Review of Benzene (Noncancer Effects). U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment, Washington Office, Washington, DC, EPA/635/R-02/001F, 2002.

Top of Page

Download(s)

This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.

If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.



Federal Register Notices

Top of Page